We are international
Donate
TEXT SIZE   


Myeloma Minute
09.01.01
Myeloma Today August 2001 Issue Available In HTML or PDF Format
What's New at the IMF?

The Comprehensive Guide to Banff: Understanding the VIIIth International Myeloma Workshop is now available for downloading as .pdf file. Download a copy for yourself and one for your doctor!

Looking for a myeloma support group? Check out our updated list of more than 60 myeloma support groups around the world.

We're having a party and you're invited! Don't miss this year's Ribbon of Hope: Making A World of Difference Gala. This year's theme is "Cirque de la Vie."


Myeloma in the News

Monday August 27 5:30 PM ET
Enzyme Blocker May Be Potent New Cancer Target

Friday August 24, 2:41 am Eastern Time
Novartis seeks wider U.S. approval of Zometa drug

Current myeloma news always available via our news page, provided by ACOR


Clinical Trials for Patients with Multiple Myeloma

Phase II Randomized Study of Bevacizumab With or Without Thalidomide in Patients With Relapsed or Refractory Multiple Myeloma
(Summary Last Modified 08/2001)

Phase II Study of AE-941 (Neovastat; Shark Cartilage) in Patients With Early Relapse or Refractory Multiple Myeloma
(Summary Last Modified 08/2001)

These trials have been added to the NCI's database of clinical trials during the month of August. To search for other clinical trials available to multiple myeloma patients, please visit our clinical trials page.


Research Updates

Differentiation of MGUS and multiple myeloma using flow cytometric characteristics of plasma cells.

Thalidomide and dexamethasone combination for refractory multiple myeloma.

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers.

Pain, mood disturbance, and quality of life in patients with multiple myeloma.


Seen and Heard...

The following obituary (printed in the Times-News, a Henderson, North Carolina paper) was recently delivered to the IMF:

"Mead Parce, former editor of the Times-News died Friday in Pardee Hospital after a 24-year battle with multiple myeloma, cancer of the bone marrow. He was in the prime of his life and his career when diagnosed with cancer in 1977 and told by his doctors that he probably only had four or five years to live. He amazed everyone by battling this incurable disease for as long as he did. Doctors call it his 'sheer force of will.'"


Myeloma Minute back issues are available online


 related articles